Publication: Identification of Marine Biotechnology Value Chains with High Potential in the Northern Mediterranean Region
Authors
Rotter, Ana ; Giannakourou, Antonia ; Marina Quero, Grazia ; Auregan, Charlène ; Triantaphyllidis, George ; Venetsanopoulou, Amalia ; De Carolis, Roberta ; Efstratiou, Chrysa ; Grigalionyte-Bembic, Ernesta ; Kotzamanis, Yannis ; Kovaˇc, Mate ; Ljubic Cmelar, Maja ; Luna, Gian Marco ; Aguilera, Cristóbal ; Acién Fernández, Francisco Gabriel ; Gómez Pinchetti, Juan Luis ; Manzo, Sonia ; Milašincic, Iva ; Nadarmija, Antun ; Parrella, Luisa ; Pinat, Massimiliano ; Roussos, Efstratios ; Ruel, Colin ; Salvatori, Elisabetta ; Sánchez Vázquez, Francisco Javier ; Skarmeta Gómez, Antonio F. ; Ulcar, Jan ; Chiavetta, Cristian ; Argente García, Jesús Enrique ; Semitiel-García, María ; Esteban Abad, María de los Ángeles ; Aboal Sanjurjo, Marina
item.page.secondaryauthor
item.page.director
Publisher
MDPI
publication.page.editor
publication.page.department
DOI
https://doi.org/10.3390/md21070416
item.page.type
info:eu-repo/semantics/article
Description
© 2023. The authors. This document is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by /4.0/
This document is the Accepted version of a Published Work that appeared in final form in Marine Drugs. To access the final edited and published work see https://doi.org/10.3390/md21070416
Abstract
Marine (blue) biotechnology is an emerging field enabling the valorization of new products and processes with massive potential for innovation and economic growth. In the Mediterranean region, this innovation potential is not exploited as well as in other European regions due to a lack of a clear identification of the different value chains and the high fragmentation of business innovation initiatives. As a result, several opportunities to create an innovative society are being missed. To address this problem, eight Northern Mediterranean countries (Croatia, France, Greece, Mar. Drugs 2023, 21, 416. https://doi.org/10.3390/md21070416 https://www.mdpi.com/journal/marinedrugs Mar. Drugs 2023, 21, 416 2 of 26 Italy, Montenegro, Portugal, Slovenia and Spain) established five national blue biotechnology hubs to identify and address the bottlenecks that prevent the development of marine biotechnology in the region. Following a three-step approach (1. Analysis: setting the scene; 2. Transfer: identification of promising value chains; 3. Capitalization: community creation), we identified the three value chains that are most promising for the Northern Mediterranean region: algae production for added-value compounds, integrated multi-trophic aquaculture (IMTA) and valorization aquaculture/fisheries/processing by-products, unavoidable/unwanted catches and discards. The potential for the development and the technical and non-technical skills that are necessary to advance in this exciting field were identified through several stakeholder events which provided valuable insight and feedback that should be addressed for marine biotechnology in the Northern Mediterranean region to reach its full potential.
publication.page.subject
Citation
Marine Drugs 2023, 21, 416
item.page.embargo
Collections
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by/4.0/